Insider Transactions Reported by 17 Insiders of Aligos Therapeutics, Inc.

Symbol
ALGS on Nasdaq
Location
South San Francisco, CA

There are no Buy or Sell transactions made by insiders since 18 Mar 2025

Aligos Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Nikhil Aneja Principal Accounting Officer 09 Mar 2026
Leonid Beigelman President, Director 15 Mar 2023
Lucinda Y. Quan Executive Vice President, Chief Business Officer and General Counsel 08 Sep 2023
Heather Preston Director 25 Jun 2025
Hardean Achneck Chief Medical Officer 08 Oct 2024
ROCHE HOLDING LTD 10%+ Owner 25 Oct 2023
James Paul Scopa Director 25 Jun 2025
Jack Nielsen Director 27 Feb 2024
Thomas Woiwode Director 23 Jun 2022
Bridget A. Martell Director 25 Jun 2025
Lesley Ann Calhoun Chief Operating Officer and Chief Financial Officer 09 Mar 2026
Julian A. Symons Executive Vice President, Chief Scientific Officer 09 Mar 2026
Matthew W. McClure Chief Medical Officer 01 Mar 2024
Lawrence M. Blatt President and CEO, Director 09 Mar 2026
Peter Hirth Director 25 Jun 2025
Carole Nuechterlein Director 25 Jun 2025
Margarita Chavez Director 25 Jun 2025

Recent Insider Transactions by Companies or Individuals for Aligos Therapeutics, Inc.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Lawrence M. Blatt ALGS Stock Option (Right to Buy) Award 105,840 105,840 09 Mar 2026 Direct
Nikhil Aneja ALGS Stock Option (Right to Buy) Award 9,450 9,450 09 Mar 2026 Direct
Lesley Ann Calhoun ALGS Stock Option (Right to Buy) Award 37,485 37,485 09 Mar 2026 Direct
Julian A. Symons ALGS Stock Option (Right to Buy) Award 23,310 23,310 09 Mar 2026 Direct
Lawrence M. Blatt ALGS Stock Option (Right to Buy) Award 179,800 179,800 16 Jul 2025 Direct
Julian A. Symons ALGS Stock Option (Right to Buy) Award 16,000 16,000 16 Jul 2025 Direct
Lesley Ann Calhoun ALGS Stock Option (Right to Buy) Award 40,185 40,185 16 Jul 2025 Direct
Carole Nuechterlein ALGS Stock Option (Right to Buy) Award 5,860 5,860 25 Jun 2025 Direct
James Paul Scopa ALGS Stock Option (Right to Buy) Award 5,860 5,860 25 Jun 2025 Direct
Peter Hirth ALGS Stock Option (Right to Buy) Award 5,860 5,860 25 Jun 2025 Direct
Heather Preston ALGS Stock Option (Right to Buy) Award 5,860 5,860 25 Jun 2025 Direct
Margarita Chavez ALGS Stock Option (Right to Buy) Award 5,860 5,860 25 Jun 2025 Direct
Bridget A. Martell ALGS Stock Option (Right to Buy) Award 5,860 5,860 25 Jun 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.